Company profile PMCB
There is not enough data for PharmaCyte Biotech to provide analysis
There is not enough data for PharmaCyte Biotech to provide correlation calculation
There is not enough data for PharmaCyte Biotech to provide analysis
There is not enough data for PharmaCyte Biotech cancer therapy to provide analysis
There is not enough data for PharmaCyte Biotech cancer therapy to provide correlation calculation
There is not enough data for PharmaCyte Biotech cancer therapy to provide analysis
There is not enough data for PharmaCyte Biotech diabetes therapy to provide analysis
There is not enough data for PharmaCyte Biotech diabetes therapy to provide correlation calculation
There is not enough data for PharmaCyte Biotech diabetes therapy to provide analysis
There is not enough data for PharmaCyte Biotech cell encapsulation to provide analysis
There is not enough data for PharmaCyte Biotech cell encapsulation to provide correlation calculation
There is not enough data for PharmaCyte Biotech cell encapsulation to provide analysis
There is not enough data for PharmaCyte Biotech pancreatic cancer therapy to provide analysis
There is not enough data for PharmaCyte Biotech pancreatic cancer therapy to provide correlation calculation
There is not enough data for PharmaCyte Biotech pancreatic cancer therapy to provide analysis
There is not enough data for PharmaCyte Biotech cannabis plant therapy to provide analysis
There is not enough data for PharmaCyte Biotech cannabis plant therapy to provide correlation calculation
There is not enough data for PharmaCyte Biotech cannabis plant therapy to provide analysis
There is not enough data for PharmaCyte Biotech ticker to provide analysis
There is not enough data for PharmaCyte Biotech ticker to provide correlation calculation
There is not enough data for PharmaCyte Biotech ticker to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. PharmaCyte Biotech news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 107 | 57 -46.7% QoQ | 188 229.8% QoQ | 55 -70.7% QoQ |
| 2020 | 165 54.2% YoY 200.0% QoQ | 36 -36.8% YoY -78.2% QoQ | 28 -85.1% YoY -22.2% QoQ | 81 47.3% YoY 189.3% QoQ |
| 2021 | 87 -47.3% YoY 7.4% QoQ | 65 80.6% YoY -25.3% QoQ | 274 878.6% YoY 321.5% QoQ | 142 75.3% YoY -48.2% QoQ |
| 2022 | 184 111.5% YoY 29.6% QoQ | 73 12.3% YoY -60.3% QoQ | 143 -47.8% YoY 95.9% QoQ | 33 -76.8% YoY -76.9% QoQ |
| 2023 | 140 -23.9% YoY 324.2% QoQ | 92 26.0% YoY -34.3% QoQ | 73 -49.0% YoY -20.7% QoQ | 120 263.6% YoY 64.4% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of PharmaCyte Biotech news was 8.21 per week. The last year interest of PharmaCyte Biotech news compared to the last 5 years has changed by -18.03%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -32.16%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. PharmaCyte Biotech stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 98 inf% QoQ | 44 -55.1% QoQ | 123 179.5% QoQ |
| 2020 | 71 inf% YoY -42.3% QoQ | 90 -8.2% YoY 26.8% QoQ | 141 220.5% YoY 56.7% QoQ | 214 74.0% YoY 51.8% QoQ |
| 2021 | 130 83.1% YoY -39.3% QoQ | 75 -16.7% YoY -42.3% QoQ | 176 24.8% YoY 134.7% QoQ | 95 -55.6% YoY -46.0% QoQ |
| 2022 | 79 -39.2% YoY -16.8% QoQ | 92 22.7% YoY 16.5% QoQ | 28 -84.1% YoY -69.6% QoQ | 45 -52.6% YoY 60.7% QoQ |
| 2023 | 27 -65.8% YoY -40.0% QoQ | 82 -10.9% YoY 203.7% QoQ | 86 207.1% YoY 4.9% QoQ | 138 206.7% YoY 60.5% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of PharmaCyte Biotech stock was 7.03 per week. The last year interest of PharmaCyte Biotech stock compared to the last 5 years has changed by -16.36%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -2.33%.